Elsevier, a global leader in medical and health information, provides technology and content solutions designed to improve healthcare quality while reducing cost. The Elsevier Clinical Decision Support (CDS) business delivers on this promise at the point of care through actionable clinical content, care planning and documentation, drug reference and decision support, learning and performance management, and data mining and outcomes analytics solutions for provider, pharmacy and payer organizations. Our world class information and point-of-care technology solutions optimize decisions and actions to improve the overall quality, safety and cost-effectiveness of care.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).